Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vaccibody AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10934
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vaccibody AS (Vaccibody) is a vaccine company that provides discovery and development of novel immunotherapies, prophylactic and therapeutic vaccines. The company develops VB10.16, a DNA based immunotherapy targeting malignancies caused by human papilloma virus. It conducts exploratory safety and immunogenicity studies for HPV16+ immunotherapy VB10.16 in women with high grade intraepithelial neoplasia. Vaccibody provides vaccines against human papilloma virus induced cancer, melanoma, prostate cancer, B cell lymphoma, multiple myeloma, influenza, herpes simplex virus 2, HIV and tuberculosis. The company partners with academic and pharmaceutical companies. Vaccibody is headquartered in Oslo, Norway.

Vaccibody AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccibody AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccibody AS, Medical Devices Deals, 2012 to YTD 2018 9
Vaccibody AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaccibody AS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Vaccibody Raises USD5.7 Million in Venture Financing 11
Vaccibody to Raise USD0.7 Million in Venture Financing 12
Vaccibody Raises US$0.97 Million In Venture Financing 13
Vaccibody Raises US$1 Million In Venture Financing 14
Partnerships 15
Vaccibody Enters into Agreement with Nektar Therapeutics 15
PharmaJet Partners with Vaccibody 16
Equity Offering 17
Vaccibody Raises USD26.2 Million in Private Placement of Shares 17
Vaccibody AS – Key Competitors 18
Vaccibody AS – Key Employees 19
Vaccibody AS – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Nov 09, 2017: Vaccibody: Quarterly report 3Q 2017 21
Aug 31, 2017: Vaccibody: Quarterly Report – 2017 Q2 23
May 10, 2017: Vaccibody: Quarterly Report – 2017 Q1 26
Mar 02, 2017: Vaccibody: Quarterly Report -2016 Q4 28
Corporate Communications 30
Dec 12, 2017: Vaccibody: Appointment of Agnete B. Fredriksen as President & CSO and Mette Husbyn as Chief Technical Officer 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Vaccibody AS, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccibody AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccibody AS, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccibody AS, Medical Devices Deals, 2012 to YTD 2018 9
Vaccibody AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaccibody Raises USD5.7 Million in Venture Financing 11
Vaccibody to Raise USD0.7 Million in Venture Financing 12
Vaccibody Raises US$0.97 Million In Venture Financing 13
Vaccibody Raises US$1 Million In Venture Financing 14
Vaccibody Enters into Agreement with Nektar Therapeutics 15
PharmaJet Partners with Vaccibody 16
Vaccibody Raises USD26.2 Million in Private Placement of Shares 17
Vaccibody AS, Key Competitors 18
Vaccibody AS, Key Employees 19

List of Figures
Vaccibody AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccibody AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccibody AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccibody AS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Craneware plc (CRW):企業の財務・戦略的SWOT分析
    Summary Craneware plc (Craneware) is a healthcare technology company that provides revenue integrity solutions. The company provides patient engagement, charge capture and pricing; coding integrity, and revenue recovery and retention products, chargemaster tool kit, online reference tool kit, physic …
  • Guangzhou Rural Commercial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Guangzhou Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guangzhou Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Omega Diagnostics Group Plc (ODX):企業の財務・戦略的SWOT分析
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company offers products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests fo …
  • Salzgitter AG:企業の戦略・SWOT・財務情報
    Salzgitter AG - Strategy, SWOT and Corporate Finance Report Summary Salzgitter AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • BNY Mellon Wealth Management:企業の戦略・SWOT・財務情報
    BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report Summary BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • American Bio Medica Corp (ABMC):企業の製品パイプライン分析2018
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Suncor Energy Inc.:企業の戦略・SWOT・財務分析
    Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The Boston Beer Company, Inc. (SAM):企業の財務・戦略的SWOT分析
    The Boston Beer Company, Inc. (SAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • GridPoint, Inc.-エネルギー分野:企業M&A・提携分析
    Summary GridPoint, Inc. (Gridpoint), a subsidiary of Twenty First Century Utilities LLC, is a provider of data-driven energy management systems. The company offers a wide range of energy management hardware including control, equipment-level sub-metering and advanced monitoring devices such as contr …
  • Sumitomo Forestry Co Ltd:企業の戦略・SWOT・財務分析
    Sumitomo Forestry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Forestry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Delphi Automotive Plc (APTV):企業の財務・戦略的SWOT分析
    Delphi Automotive Plc (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Boston Consulting Group:企業の戦略・SWOT・財務分析
    The Boston Consulting Group - Strategy, SWOT and Corporate Finance Report Summary The Boston Consulting Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Talanx AG:戦略・SWOT・企業財務分析
    Talanx AG - Strategy, SWOT and Corporate Finance Report Summary Talanx AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Power Grid Corporation of India Limited:企業の戦略・SWOT・財務分析
    Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report Summary Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • MediWound Ltd (MDWD):医療機器:M&Aディール及び事業提携情報
    Summary MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’ …
  • EV Energy Partners LP:企業のM&A・事業提携・投資動向
    EV Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EV Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. AFC Energy power generation technology is used in the industrial markets and produces heat, water, and electricity. The company provides its electricity for industrial a …
  • Sinofert Holdings Ltd (297):企業の財務・戦略的SWOT分析
    Sinofert Holdings Ltd (297) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆